The new CalRx insulin will hit the market in January at $55 a month, part of a broader state effort to rein in drug costs.

The City of Charlotte is suing pharmaceutical companies over inflated insulin prices, alleging they have overpaid millions for the medicine through their employee health plans.

And the market for insulin has changed fast. Since 2023, drug companies have cut costs voluntarily, spurred by government ...

California lawmakers and Gov. Gavin Newsom have approved more than 900 new laws that will begin to take effect starting on Jan. 1, 2025. They include measures to cap insulin co-pays, ban cat declawing ...

Pharmacies in Omaha are sending patients to other locations to find what they need as insulin is on back order throughout the ...

McGill University researchers have identified a brain function that helps explain why childhood stress raises metabolic ...

Inhaled insulin shows safety and high treatment satisfaction in youth with type 1 diabetes over 26 weeks but does not meet ...

The partnership is the first time Medtronic has integrated its insulin pumps with a sensor developed outside of the company.

More than a million Americans with diabetes may be skipping insulin doses or delaying purchase of the drug because of its expense, said authors of a new study. Based on data from 982 insulin users ...

This review synthesizes evidence that gut microbiota dysbiosis contributes to insulin resistance and symptom severity in ...

Scientists at the University of Wisconsin–Madison have uncovered a possible way to protect key cells in the pancreas that are ...

Unlike our organs, cell organelles such as mitochondria are not fixed in place, but when, where, how, and why organelles move ...